Primary Biliary Cholangitis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Primary Biliary Cholangitis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, June 27, 2024 /EINPresswire.com/ -- The primary biliary cholangitis (PBC) market has experienced significant growth, with a valuation of $0.87 billion in 2023 expected to increase to $0.98 billion in 2024, marking a compound annual growth rate (CAGR) of 12.1%. It will grow to $1.46 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%.  This growth is attributed to heightened disease awareness, increased global healthcare expenditure, strategic healthcare sector collaborations, and government initiatives promoting liver health.

Increasing Smoking Rates Propel Market Growth
The rise in smoking rates globally is anticipated to drive further growth in the primary biliary cholangitis market. Smoking is a well-established risk factor for liver diseases, including PBC, prompting more individuals to seek medical attention for related issues.

Explore the primary biliary cholangitis market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=13520&type=smp

Major Players and Market Trends
Key players in the PBC market, such as Pfizer Inc., F. Hoffmann-La Roche Ltd., and Merck And Co. Inc., are actively developing innovative treatments, including orphan drugs like obeticholic acid (OCA) combined with bezafibrates, aimed at gaining market exclusivity and improving treatment outcomes.
For instance, Intercept Pharmaceuticals, Inc. received FDA orphan drug designation for the combination of OCA and bezafibrate in May 2023, highlighting advancements in PBC treatment.

Market Segments
The primary biliary cholangitis market is segmented based on:
• Treatment Type: Drugs, Liver Transplantation
• Diagnosis: Imaging Tests, MRE, MRCP, Ultrasound, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses
• End-Users: Specialty Clinics, Homecare, Other End-Users

Regional Insights: Asia-Pacific Leading Growth
North America dominated the PBC market in 2023, with Asia-Pacific expected to witness the highest growth rate during the forecast period. Detailed regional dynamics and growth opportunities can be explored in the comprehensive report.

You can directly purchase the PBC market gmr 2024 here -
https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

Primary Biliary Cholangitis Global Market Report 2024 from TBRC covers the following information:
1. Market size data for the forecast period: Historical and Future
2. Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
3. Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Primary Biliary Cholangitis Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on primary biliary cholangitis market size, primary biliary cholangitis market drivers and trends, primary biliary cholangitis market major players, competitors' revenues, market positioning, and market growth across geographies. The primary biliary cholangitis market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Gastroesophageal Reflux Disease (GERD) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Migraine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

Myelodysplastic Syndrome Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.